Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,847
datasets available to search
ShareScore release 0.9.0
Dataset results
1,847 results for “Psoriasis”
Safety and Efficacy Study of CF101 to Treat Psoriasis
ClinicalTrials.gov study NCT00428974. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Maximal Use Study of Tapinarof Cream, 1% in Adults With Extensive Plaque Psoriasis
ClinicalTrials.gov study NCT04042103. IPD Sharing: NO. Countries: 1. Publications: 1.
Randomized Placebo-controlled Study of ISA247 in Plaque Psoriasis
ClinicalTrials.gov study NCT00244842. IPD Sharing: NO. Countries: 1. Publications: 4.
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT00936065. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens
ClinicalTrials.gov study NCT01406938. IPD Sharing: Not stated. Countries: 16. Publications: 2.
An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equ
ClinicalTrials.gov study NCT02698475. IPD Sharing: Not stated. Countries: 9. Publications: 1.
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Ca
ClinicalTrials.gov study NCT04908475. IPD Sharing: YES. Countries: 5. Publications: 1.
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis Two of Two Phase 3 Studies
ClinicalTrials.gov study NCT00689481. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02561806. IPD Sharing: YES. Countries: 13. Publications: 3.
A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)
ClinicalTrials.gov study NCT01646177. IPD Sharing: YES. Countries: 10. Publications: 13.
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT06095115. IPD Sharing: YES. Countries: 16. Publications: 1.
The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira® and BI 695501 in Patients With Plaque Psoriasis
ClinicalTrials.gov study NCT03210259. IPD Sharing: Not stated. Countries: 7. Publications: 1.
P3 Study Brodalumab in Treatment of Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT01708603. IPD Sharing: YES. Countries: 11. Publications: 6.
Fluphenazine Hydrochloride for Psoriasis
ClinicalTrials.gov study NCT00929578. IPD Sharing: NO. Countries: 1. Publications: 1.
Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis
ClinicalTrials.gov study NCT03431974. IPD Sharing: NO. Countries: 1. Publications: 1.
A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
ClinicalTrials.gov study NCT02564042. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Spesolimab (BI 655130) Single Dose in Generalized Pustular Psoriasis
ClinicalTrials.gov study NCT02978690. IPD Sharing: NO. Countries: 6. Publications: 1.
A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With Psoriasis
ClinicalTrials.gov study NCT03718299. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis
ClinicalTrials.gov study NCT02129777. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Vascular Inflammation in Psoriasis - Extension Study
ClinicalTrials.gov study NCT01866592. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.